MADERNA; Andreas

Patent Applications and Registrations

Patent applications and USPTO patent grants for MADERNA; Andreas.The latest application filed is for "5h-pyrrolo[3,2-d]pyrimidine-2,4-diamino compounds and antibody conjugates thereof".

Company Profile

13.26.29

MADERNA; Andreas - South San Francisco CA
Maderna; Andreas - San Diego CA
Maderna; Andreas - Walnut Creek CA
MADERNA; Andreas - Escondido CA
Maderna; Andreas - Stony Point NY
Maderna; Andreas - Los Angeles CA
MADERNA; Andreas - Tappan NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
5H-PYRROLO[3,2-d]PYRIMIDINE-2,4-DIAMINO COMPOUNDS AND ANTIBODY CONJUGATES THEREOF App 20220242871 - MADERNA; Andreas ; et al.	2022-08-04
Bifunctional cytotoxic agents containing the CTI pharmacophore Grant 11,365,263 - Maderna , et al. June 21, 2	2022-06-21
Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20210230196 - Wythes; Martin James ; et al.	2021-07-29
Cyclopentane-based modulators of STING (stimulator of interferon genes) Grant 10,968,242 - Wythes , et al. April 6, 2	2021-04-06
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore App 20210061923 - MADERNA; Andreas ; et al.	2021-03-04
Immunomodulator Antibody Drug Conjugates And Uses Thereof App 20200405813 - YAM; Alice ; et al.	2020-12-31
Bifunctional cytotoxic agents containing the CTI pharmacophore Grant 10,870,706 - Maderna , et al. December 22, 2	2020-12-22
Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents Grant 10,662,204 - Planken , et al.	2020-05-26
Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20200102334 - Wythes; Martin James ; et al.	2020-04-02
Tetrahydroquinazoline derivatives useful as anticancer agents Grant 10,590,115 - Planken , et al.	2020-03-17
3-indol substituted derivatives, pharmaceutical compositions and methods for use Grant 10,544,095 - Ninkovic , et al. Ja	2020-01-28
Cyclopentane-based modulators of STING (stimulator of interferon genes) Grant 10,538,542 - Wythes , et al. Ja	2020-01-21
Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20190284216 - Wythes; Martin James ; et al.	2019-09-19
Bifunctional cytotoxic agents Grant 10,391,182 - Maderna , et al. A	2019-08-27
Tetrahydroquinazoline Derivatives Useful as Anticancer Agents App 20190248767 - PLANKEN; Simon ; et al.	2019-08-15
Substituted Quinazoline and Pyridopyrimidine Derivatives Useful as Anticancer Agents App 20190233440 - PLANKEN; Simon ; et al.	2019-08-01
Bifunctional Cytotoxic Agents App 20180339060 - MADERNA; Andreas ; et al.	2018-11-29
Bifunctional cytotoxic agents Grant 10,086,085 - Maderna , et al. October 2, 2	2018-10-02
Novel 3-indol Substituted Derivatives, Pharmaceutical Compositions And Methods For Use App 20180222862 - Ninkovic; Sacha ; et al.	2018-08-09
3-indol substituted derivatives, pharmaceutical compositions and methods for use Grant 9,873,690 - Ninkovic , et al. January 23, 2	2018-01-23
Derivatives Of N-(arylamino) Sulfonamides As Inhibitors Of Mek App 20170183333 - Maderna; Andreas ; et al.	2017-06-29
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore App 20160271270 - MADERNA; Andreas ; et al.	2016-09-22
Novel 3-indol Substituted Derivatives, Pharmaceutical Compositions And Methods For Use App 20160272628 - Ninkovic; Sacha ; et al.	2016-09-22
Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide Grant 9,296,686 - Maderna , et al. March 29, 2	2016-03-29
Cytotoxic peptides and antibody drug conjugates thereof Grant 9,249,186 - Doroski , et al. February 2, 2	2016-02-02
Cytotoxic Peptides And Antibody Drug Conjugates Thereof App 20150307551 - DOROSKI; Matthew David ; et al.	2015-10-29
Preparation Of (r)-n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide And (s)- N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-di- Hydroxypropyl)cyclopropane-1-sulfonamide App 20150274651 - MADERNA; Andreas ; et al.	2015-10-01
Cytotoxic peptides and antibody drug conjugates thereof Grant 9,138,486 - Doroski , et al. September 22, 2	2015-09-22
Bifunctional Cytotoxic Agents App 20150209445 - MADERNA; Andreas ; et al.	2015-07-30
Derivatives Of N-(arylamino) Sulfonamides As Inhibitors Of Mek App 20140378466 - Maderna; Andreas ; et al.	2014-12-25
Cytotoxic Peptides And Antibody Drug Conjugates Thereof App 20140363452 - DOROSKI; Matthew David ; et al.	2014-12-11
Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide Grant 8,884,058 - Maderna , et al. November 11, 2	2014-11-11
Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK Grant 8,829,052 - Maderna , et al. September 9, 2	2014-09-09
Cytotoxic peptides and antibody drug conjugates thereof Grant 8,828,401 - Doroski , et al. September 9, 2	2014-09-09
Preparation Of (r)-n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide And (s)- N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-di- Hydroxypropyl)cyclopropane-1-sulfonamide App 20130261320 - MADERNA; Andreas ; et al.	2013-10-03
Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-3,4-difluoro-2(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-- dihydroxypropyl)cyclopropane-1-sulfonamide Grant 8,513,443 - Maderna , et al. August 20, 2	2013-08-20
Cytotoxic Peptides And Antibody Drug Conjugates Thereof App 20130129753 - DOROSKI; Matthew David ; et al.	2013-05-23
Preparation Of (r)-n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamin0)-6-methoxyphenyl)-1-(2,- 3-dihydroxypropyl)cyclopropane-1-sulfonamide And (s)- N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamin0)-6-methoxyphenyl)-1-(2,3-di- Hydroxypropyl)cyclopropane-1-sulfonamide App 20120178946 - Maderna; Andreas ; et al.	2012-07-12
Derivatives Of N-(arylamino)sulfonamides As Inhibitors Of Mek App 20120022076 - MADERNA; Andreas ; et al.	2012-01-26
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK Grant 8,101,799 - Maderna , et al. January 24, 2	2012-01-24
Inhibitors of MEK Grant 8,063,049 - Koh , et al. November 22, 2	2011-11-22
Inhibitors Of Mek App 20100331334 - Koh; Yung-hyo ; et al.	2010-12-30
Inhibitors of MEK Grant 7,820,664 - Vernier , et al. October 26, 2	2010-10-26
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK Grant 7,759,518 - Maderna , et al. July 20, 2	2010-07-20
Phenylamino isothiazole carboxamidines as MEK inhibitors Grant 7,652,047 - Abdellaoui , et al. January 26, 2	2010-01-26
Derivatives Of N-(arylamino) Sulfonamides As Inhibitors Of Mek App 20090082457 - MADERNA; Andreas ; et al.	2009-03-26
Phenylamino Isothiazole Carboxamidines As Mek Inhibitors App 20080306063 - Abdellaoui; Hassan ; et al.	2008-12-11
Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof App 20080293712 - WISSNER; Allan ; et al.	2008-11-27
Inhibitors of MEK App 20080255133 - Vernier; Jean-Michel ; et al.	2008-10-16
Phenylamino isothiazole carboxamidines as MEK inhibitors Grant 7,429,667 - Abdellaoui , et al. September 30, 2	2008-09-30
Derivatives Of N-(arylamino) Sulfonamides As Inhibitors Of Mek App 20080058340 - Maderna; Andreas ; et al.	2008-03-06
Phenylamino isothiazole carboxamidines as MEK inhibitors App 20060194802 - Abdellaoui; Hassan ; et al.	2006-08-31
Ether and ester derivatives of the perborate icosahedron Grant 6,664,426 - Hawthorne , et al. December 16, 2	2003-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.